HIV-1 genotypic resistance profile of patients failing antiretroviral therapy in Paraná, Brazil
✍ Scribed by Toledo, Paula Virginia Michelon; de Carvalho, Denise Siqueira; Romagnoli, Luiza; Marcinko, Gustavo; da Cunha, Clovis Arns; de Souza, Margely Nunes; Brindeiro, Rodrigo; de Queiroz-Telles, Flávio
- Book ID
- 122703921
- Publisher
- SciELO
- Year
- 2010
- Tongue
- English
- Weight
- 959 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1413-8670
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The extent to which HIV‐1 proviral DNA mutations cause clinically relevant antiretroviral resistance is still controversial. Paired plasma HIV‐1 RNA and whole blood DNA were compared in patients failing HAART to investigate if the additional knowledge of archived mutations could improve
The emergence of mutations encoding drug resistance is supposed to be a significant limitation to the clinical efficacy of inhibitor compounds directed against specific HIV-1 enzymatic targets. We have used a commercial test (Visible Genetics Inc., Paris, France) to study the prevalence of mutations